What does lymphovascular invasion mean on a pathology report

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Lymphovascular Invasion on Your Pathology Report

Lymphovascular invasion (LVI) is an important finding that pathologists look for when examining cancer tissue under a microscope. Let me explain what it means and why it matters.

What It Is

Lymphovascular invasion means that cancer cells have invaded into the lymphatic vessels (tiny channels that carry fluid through your body) or blood vessels within or near the tumor. When pathologists examine your tissue sample, they're looking for evidence that cancer cells have actually entered these vessels, not just grown near them.

Think of it this way: if the tumor is like a city, lymphatic and blood vessels are like highways. LVI means cancer cells have gotten onto those highways, which could potentially allow them to travel to other parts of your body.

Why Doctors Care About This Finding

According to NCCN (National Comprehensive Cancer Network) Guidelines, lymphovascular invasion is considered a prognostic factor—meaning it helps doctors understand:

  • How aggressive the cancer appears to be
  • Whether there's a higher risk the cancer could spread to lymph nodes or distant organs
  • Whether additional treatment (like chemotherapy) might be recommended even if lymph nodes appear cancer-free

The presence of LVI often influences treatment recommendations because it suggests the cancer has already shown an ability to enter the circulatory system.

What This Means for Your Care

The significance of LVI depends on:

  • Your cancer type (breast, colon, lung, etc.)
  • Whether it's present or absent (some cancers are more concerning with LVI than others)
  • Other factors in your pathology report (tumor grade, stage, hormone receptors, etc.)

Questions to Ask Your Oncologist

Since LVI was noted in your report, here are important questions for your care team:

  1. "How does the lymphovascular invasion in my case affect my treatment recommendations?"
  2. "Does this finding change whether I need chemotherapy or other systemic treatment?"
  3. "What does this mean for my prognosis and follow-up care?"
  4. "Are there other findings in my pathology report that work together with the LVI to guide treatment?"
  5. "What should I be monitoring for during follow-up?"

Your oncologist will interpret this finding in the context of your complete pathology report and clinical situation to determine the best treatment approach for you specifically.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2